Mustang Bio, Inc. (MBIO) has a negative trailing P/E of -2.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -35.42%.
Criteria proven by this page:
Overall SharesGrow Score: 69/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -1,015.8 | -126.03 | 529.48 | 0.00 | - |
| 2017 | -483.9 | -3.09 | 253.03 | 0.00 | - |
| 2018 | -129.2 | 15.90 | 108.85 | 0.00 | - |
| 2019 | -152.8 | -8.81 | 142.43 | 0.00 | - |
| 2020 | -165.8 | 11.34 | 101.11 | 0.00 | - |
| 2021 | -109.9 | 3.30 | 64.90 | 0.00 | - |
| 2022 | -26.3 | 20.02 | 44.14 | 0.00 | - |
| 2023 | -11.3 | 0.24 | 4,721.76 | 0.00 | - |
| 2024 | -3.4 | 0.06 | -14.00 | 0.00 | 1.13% |
| 2025 | -25.1 | 0.30 | 5.05 | 0.00 | 0.57% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-7.24 | $0.00 | $-12.65M | - |
| 2017 | $-18.58 | $0.00 | $-31.29M | - |
| 2018 | $-17.07 | $0.00 | $-30.66M | - |
| 2019 | $-20.03 | $0.00 | $-48.16M | - |
| 2020 | $-17.73 | $0.00 | $-62.15M | - |
| 2021 | $-10.94 | $0.00 | $-64.08M | - |
| 2022 | $-11.44 | $0.00 | $-78.89M | - |
| 2023 | $-6.00 | $0.00 | $-51.6M | - |
| 2024 | $-2.57 | $0.00 | $-15.75M | - |
| 2025 | $-0.39 | $0.00 | $-1.92M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-99.00 | $-99.00 – $-99.00 | $11M | $11M – $11M | 1 |
| 2027 | $-51.50 | $-51.50 – $-51.50 | $55.6M | $55.6M – $55.6M | 1 |
